OncLive | Bringing the Global Oncology Community Together

The European Commission has approved the combination of encorafenib (Braftovi) and binimetinib (Mektovi) for the treatment of adult patients with BRAF V600–mutant unresectable or metastatic melanoma.Read More >>

Expert Addresses Advances and Challenges in Myeloma

CAR T-Cell Therapy Brings Hope to Relapsed/Refractory Myeloma

Diagnosis of ITP Remains a Challenge for Clinicians

CLL Paradigm Continues to Be Refined

View More Stories >>

View Conference Coverage

2018 International Liver Cancer Association Annual Conference

2018 International Lung Cancer Congress

2018 Pan Pacific Lymphoma Conference

2nd Annual Live Medical Crossfire® : Hematologic Malignancies

State of the Science Summit on A Summer of Progress: Updates from ASCO 2018

Dr. Gentzler on Combination Therapies in NSCLC

Dr. Graff on Novel Therapies in Metastatic Breast Cancer

Dr. Singh on Treatment for Patients With Uterine Leiomyosarcoma

Dr. Madduri Discusses Checkpoint Inhibitors in Myeloma

Dr. Shiller on Next-Generation Sequencing in GI Cancers

Dr. Haigentz on the Impact of Immunotherapy in Head and Neck Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Management of Regional Colorectal Cancer Metastases

Recognizing HCC Risk Factors

HCC Staging Systems Explored

PARP Combination Therapies in Ovarian Cancer

Future Outlook: Treating Advanced Melanoma

Ongoing PARP Trials in Recurrent Ovarian Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Establishing the Role of FLT3 Mutations in AML

Breaking Down the Epidemiology of AML

Molecular Testing Through Multiple Labs in NSCLC

Adequate Tissue Collection for Molecular Testing in NSCLC

Managing Patients on Lenvatinib/Everolimus in mRCC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

NTRK Gene Fusions: Novel Targets for Tumor-Agnostic Cancer Therapy

Over the past few decades, our knowledge of the role of gene mutations in oncogenesis has transformed cancer care.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

Priority Review in NSCLC, Label Update in CLL, Delayed FDA Decision in Lung Cancer, and More